Crescent Biopharma Inc.
CBIO | NASDAQ
$12.75
-$0.73 (-5.42%)
Nov 2, 2026, 2:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -165.12M | -162.08M | -153.94M | -68.77M | -53.99M | -42.29M | -37.88M | -39.74M | -39.11M | -37.28M | -36.9M | -38.07M | -37.39M | -42.4M | -46.69M | -53.87M | -62.67M | -63.81M | -63.43M | -61.57M | -57.96M | -57.64M |
Depreciation & Amortization | 212K | 148K | 84K | 30K | 10.13K | 20.55K | 35.17K | 58.47K | 93.09K | 124.08K | 153.3K | 175.72K | 180.32K | 191.68K | 207.15K | 223.07K | 243.11K | 255.82K | 264.6K | 271.31K | 270.46K | 270.65K |
Stock-Based Compensation | 14.81M | 16.18M | 13.3M | 9.72M | 8.87M | 4.77M | 4.77M | 4.56M | 4.31M | 3.92M | 3.56M | 3.52M | 3.54M | 3.65M | 3.86M | 4.28M | 4.96M | 5.55M | 6.09M | 6.39M | 6.49M | 6.69M |
Other Working Capital | -20.89M | -23.62M | -15.45M | 7.45M | 4.53M | 5.32M | 1.7M | -1.18M | -2.46M | -1.64M | -2.46M | -1.16M | -1.28M | -4.86M | -3.52M | -2.26M | -3.09M | 31.81K | -1.18M | -517.02K | 1.74M | 1.1M |
Other Non-Cash Items | 78.62M | 82.49M | 82.4M | 2.27M | 2.68M | 646.91K | 814.48K | 1.04M | 766.92K | 815.32K | 864.87K | 882.6K | 864.1K | 848.81K | 828.51K | 808.74K | 789.5K | 767.27K | 751.21K | 733.48K | 716.13K | 699.34K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.19M | -6.37M | -13.37M | 8.26M | 3.48M | 5.41M | 1.16M | -932.87K | -1.75M | -1.36M | -2.56M | -1.68M | -2.31M | -6.66M | -4.66M | -2.8M | -2.99M | 167.19K | -1.17M | -200.2K | 1.55M | 107.51K |
Operating Cash Flow | -72.68M | -69.62M | -71.53M | -48.49M | -38.95M | -31.44M | -31.1M | -35.01M | -35.7M | -33.78M | -34.88M | -35.18M | -35.11M | -44.37M | -46.46M | -51.35M | -59.68M | -57.06M | -57.49M | -54.37M | -48.93M | -49.87M |
Capital Expenditures | -80.94M | -81.07M | -72.92M | -726K | -140K | -2.54K | -9.97K | -10.78K | -18.64K | -26.64K | -21.39K | -20.59K | -15.21K | -45.87K | -84.19K | -86.64K | -88.49K | -52.4K | -14.94K | -50.67K | -62.15K | -63.43K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -78.23M | -80M | -72M | 30K | 30K | 30K | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -79.17M | -81.07M | -72.92M | -696K | -110K | 27.47K | 20.03K | -10.77K | -18.64K | -26.64K | -21.39K | -20.59K | -15.21K | -45.87K | -84.19K | -86.64K | -88.49K | -52.4K | -14.94K | -50.67K | -62.15K | -63.43K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.09M | 139.92M | 145.37M | 145.55M | 145.37M | -1.49M | 5.4K | 6.4K | 68.01K | 87.63K | 116.5K | 115.5K | 53.88K | 33.77K | n/a | n/a | n/a | n/a | 4.24K | 187.95K | 187.95K | 193.56K |
Financial Cash Flow | 170.8M | 317.53M | 322.98M | 144.12M | 145.38M | -1.49M | 5.4K | 6.4K | 68.01K | 87.63K | 28.82M | 32.98M | 32.92M | 32.9M | 4.16M | 1.14M | 1.16M | 1.16M | 10.72M | 13.47M | 18M | 27.58M |
Net Cash Flow | 18.95M | 166.84M | 178.53M | 94.93M | 106.32M | -32.9M | -31.07M | -35.02M | -35.65M | -33.72M | -6.08M | -2.22M | -2.21M | -11.51M | -42.38M | -50.3M | -58.61M | -55.95M | -46.78M | -40.95M | -30.99M | -22.35M |
Free Cash Flow | -153.62M | -150.68M | -144.45M | -49.22M | -39.09M | -31.44M | -31.11M | -35.02M | -35.72M | -33.81M | -34.9M | -35.2M | -35.13M | -44.41M | -46.54M | -51.44M | -59.77M | -57.11M | -57.5M | -54.42M | -48.99M | -49.93M |
Adj. Free Cash Flow | -168.43M | -166.87M | -157.75M | -58.93M | -47.96M | -36.22M | -35.88M | -39.58M | -40.03M | -37.73M | -38.46M | -38.71M | -38.67M | -48.06M | -50.4M | -55.72M | -64.73M | -62.67M | -63.59M | -60.81M | -55.48M | -56.62M |
Maintenance CapEx | -66.74M | -66.87M | -66.8M | -726K | -140K | -2.54K | -9.97K | -9.97K | -17.84K | -25.84K | -20.59K | -20.59K | -15.21K | -4.68K | -43.01K | -45.45K | -47.3K | -52.35K | -14.89K | -12.44K | -8.11K | -9.44K |
Growth CapEx | -14.2M | -14.2M | -6.12M | n/a | n/a | n/a | n/a | -801 | -801 | -801 | -801 | n/a | n/a | -41.19K | -41.19K | -41.19K | -41.19K | -56 | -56 | -38.23K | -54.04K | -53.99K |
Owner Earnings | -139.42M | -136.48M | -138.33M | -49.22M | -39.09M | -31.44M | -31.11M | -35.02M | -35.72M | -33.81M | -34.9M | -35.2M | -35.13M | -44.37M | -46.5M | -51.4M | -59.73M | -57.11M | -57.5M | -54.38M | -48.93M | -49.88M |
Add to Watchlist
Select watchlists to add or remove CBIO